CTIM-09. INB-200: FULLY ENROLLED PHASE 1 STUDY OF GENE-MODIFIED AUTOLOGOUS GAMMA-DELTA (ΓΔ) T CELLS IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS RECEIVING MAINTENANCE TEMOZOLOMIDE (TMZ)

Authors: Mina Lobbous, Trishna Goswami, Larry Lamb, Kate Rochlin, Thiru Pillay, Mariska ter Haak, Louis B Nabors

Published: 2024-11-11

DOI: 10.1093/neuonc/noae165.0342

Source: Full article